Idexx Laboratories Europe, the Middle East, and Africa — Total Assets increased by 9.6% to $101.71M in Q4 2025 compared to the prior quarter.
An increase suggests regional expansion or investment in infrastructure, while a decrease may indicate asset divestiture or improved capital efficiency. Rapid growth relative to revenue may signal declining asset turnover, whereas stable growth suggests balanced regional scaling.
This metric represents the total book value of all resources, equipment, inventory, and receivables specifically allocat...
Peers in the veterinary diagnostics or medical device space typically report regional asset bases proportional to their local market share and distribution network complexity.
idxx_segment_europe_the_middle_east_and_africa_total_assets| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $96.38M | $92.82M | $101.71M |
| QoQ Change | — | -3.7% | +9.6% |
| YoY Change | — | -3.7% | +9.6% |